Shows
The Studio at Kendall SquareLisa Deschamps of AviadoBio and Richard Wilson of Astellas discuss the field of AAV gene therapy, and their partnership on AVB-101, an AAV gene therapy for frontotemporal dementia (FTD)Lisa and Richard describe the unmet need for frontotemporal dementia and their partnership on AVB-101, which is administered directly to the thalamus. They describe the unique perspectives and skill sets that larger and smaller companies bring to the table in these types of partnerships, and discuss their thoughts on making it through times of change for the benefit of patients.2025-06-1821 min
The BioHub: The Top Voices in BiotechEpisode 49 - Lisa Deschamps- CEO of AviadobioWelcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry.I’m joined by Lisa Deschamps, CEO of AviadoBio.After 25 years at Novartis, leading global launches in gene therapy, she’s now at the helm of AviadoBio—developing treatments for FTD and ALS.We talk career moves, mindset, culture, and what’s ahead.Enjoy and stay tuned.2025-05-2029 min
BioBossLisa Deschamps: CEO of AviadoBioLisa Deschamps, CEO of AviadoBio, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how AviadoBio is working to develop transformative medicines for patients living with debilitating and life-threatening neurodegenerative disorders.2023-09-1146 min